Panel Discussions and Closing Remarks

Panel Member(s):

• Martijn van der Plas, MEB-Medical Evaluations Board
• Mats Welin, Swedish Medical Products Agency
• Christopher Storbeck, Health Canada
• Brian K. Nunnally, Seqirus, A CSL Company
• Roger Nosal, Pfizer, Inc.
• Sarah Pope Miksinski, Gilead Sciences, Inc.

Session Speaker(s):

• JR Dobbins, Eli Lilly and Company